Notable Analyst Rating Changes 5/21: TGT, FCX, CME, THC, CSIQ Upgraded; PETM, VALE, POT Downgraded
More News related to CME
- CME Group (CME) Announces Dealer Backing for CDS Initiative
- CME Group Announces Dealer Founding Members for CDS Initiative
- CME Group's Duffy to Testify before Senate Committee on Agriculture
- CME Group Volume Averaged 10.8 Million Contracts per Day in November 2009, Up 5 Percent from November 2008
- CME Group, KRX Announce After-hours Access to KOSPI 200 Futures on CME Globex
More News related to CSIQ
- Canadian Solar Announces Intention to Build Solar Panel Manufacturing Facility in Ontario
- Solar Energy Initiatives, Inc. Announces $1.7 Million Solar Project
- Solar Stocks See Relative Strength: STP, YGE, LDK, more...
- Solar Energy Initiatives, Inc. Signs Financing Agreement for Municipal Solar Projects
- Canadian Solar (CSIQ) Posts Q3 EPS of $0.69, Tops Views; Guides Q409, FY09, and FY10 Shipments
More News related to FCX
- Goldman Sachs Removes Freeport-McMoRan (FCX) from its Conviction Buy List
- Freeport McMoRan (FCX) volatility near 25-month lows; gold above $1170
- Trading Overview for Harmony Gold Mining Co. Ltd. Issued by StockPreacher.com
- ETF Movers: XLF, XLB, TAN, USO, GLD Up; FAZ, IYT, KRE Lower
- Freeport McMoRan (FCX) volatility at 17-month lows
More News related to Special Reports
- Unilever (UL) Annouces Total Recall of Slim-Fast Cans
- Steris (STE) Sinks After FDA Notice on Concerns About the Steris System 1 Processor
- Watson Pharmaceuticals (WPI) Files New Drug Application with FDA for Generic Rozerem
- St. Jude (STJ) Receives U.S. FDA Approval for Penta Surgical Lead
- AstraZeneca (AZN) Gets U.S. FDA Approval for SEROQUEL XR Antidepressants
UPGRADES:
UBS upgrades Target (NYSE: TGT) from Neutral to Buy. Price target $52.
JP Morgan upgrades Freeport-McMoRan (NYSE: FCX) from Neutral to Overweight.
Goldman Sachs upgrades CME Group Inc. (NYSE: CME) from Neutral to Buy and raised its price target from $215 to $330.
Barclays upgrades Tenet Healthcare (NYSE: THC) from Equalweight to Overweight.
Oppenheimer upgrades Canadian Solar (Nasdaq: CSIQ) from Perform to Outperform. Price target $14.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES:
Goldman Sachs downgrades PetSmart (Nasdaq: PETM) from Buy to Neutral.
Morgan Stanley downgrades Vale (Nasdaq: VALE) from Equalweight to Underweight.
TD Newcrest downgrades Potash Corp. of Saskatchewan (NYSE: POT) from Buy to Hold. Click here for more color.
For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades
NEW COVERAGE:
Soleil Securities initiates coverage on Marriott International (NYSE: MAR) with a Buy. Price target $30.
William Blair initiates coverage on Perrigo (Nasdaq: PRGO) with an Outperform.
Soleil Securities initiates coverage on Priceline.com (Nasdaq: PCLN) with a Hold. Price target $112.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Related Categories
Special ReportsStocks Mentioned
+0.62
-0.22Related Entities
- UBS
- William Blair
- JPMorgan
- Goldman Sachs
- Morgan Stanley
- Soleil Securities
- Barclays
- TD Newcrest
- Notable Analyst Rating Changes
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
